Isabelle Lefebvre
About Isabelle Lefebvre
Isabelle Lefebvre: Chief Regulatory Officer
Isabelle Lefebvre serves as the Chief Regulatory Officer. With a career spanning over three decades, she has amassed extensive experience in global regulatory affairs and compliance. She brings a wealth of expertise to her current role, specializing in regulatory strategies that drive drug development across various phases.
Isabelle Lefebvre's Educational Background
Isabelle Lefebvre holds a B.S. in Biochemistry from the University of Montreal. She furthered her education by earning an M.S. in Regulatory Affairs from Northeastern University. This strong educational foundation has supported her extensive career in regulatory affairs and compliance.
Isabelle Lefebvre's Expertise in Ophthalmic and Ocular Conditions
Isabelle Lefebvre specializes in regulatory affairs related to ophthalmic and ocular conditions. Throughout her career, she has successfully led the approval processes for significant ocular drug products, demonstrating her proficiency and deep understanding of this specialized field.
Career History: Isabelle Lefebvre
Isabelle Lefebvre has held notable positions in her career, including Vice President, Head of Regulatory Science at Hengrui USA. She has also occupied senior roles in regulatory strategy and affairs at globally recognized pharmaceuticals such as Lundbeck, Inc., Alpharma Pharmaceuticals, and Bristol-Myers Squibb. Her leadership roles at these organizations underscore her significant contributions to the field.
Isabelle Lefebvre's Achievements in Drug Approvals
During her tenure at Bausch Health Companies, Inc., Isabelle Lefebvre led the successful approvals of two important ocular drug products, LOTEMAX gel and VYZULTA. These achievements highlight her effective leadership and expertise in regulatory affairs, significantly impacting patient care in the field of ophthalmology.